Jefferies Group’s AstraZeneca AZN Stock Holding History

Jefferies Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.47M	Sell	22,500 -12,500	-36%	-$1.59M	0.02%	533
2022 Q2	$4.62M	Buy	35,000 +12,500	+56%	+$1.64M	0.04%	376
2022 Q1	$2.99M	Sell	22,500 -10,650	-32%	-$1.28M	0.02%	549
2021 Q4	$3.86M	Buy	33,150 +4,450	+16%	+$524K	0.02%	558
2021 Q3	$3.45M	Hold	28,700	–	–	0.03%	551
2021 Q2	$3.44M	Buy	28,700 +18,050	+169%	+$1.98M	0.02%	573
2021 Q1	$1.06M	Sell	10,650 -1,850	-15%	-$186K	0.01%	882
2020 Q4	$1.25M	Hold	12,500	–	–	0.01%	859
2020 Q3	$1.37M	Sell	12,500 -32,500	-72%	-$3.61M	0.02%	706
2020 Q2	$4.76K	Buy	+45,000	New	+$4.65M	0.06%	286
2018 Q2	–	Sell	-56,900	Closed	-$3.98M	–	2302
2018 Q1	$3.98M	Buy	56,900 +6,000	+12%	+$416K	0.02%	559
2017 Q4	$3.53M	Buy	+50,900	New	+$3.43M	0.02%	707
2017 Q3	–	Sell	-15,400	Closed	-$1.05M	–	2324
2017 Q2	$1.05M	Buy	+15,400	New	+$1.01M	0.01%	1274
2015 Q1	–	Sell	-9,000	Closed	-$633K	–	2076
2014 Q4	$633K	Sell	9,000 -254,900	-97%	-$18.3M	﹤0.01%	1175
2014 Q3	$18.9M	Sell	263,900 -363,000	-58%	-$26.6M	0.13%	144
2014 Q2	$46.6M	Buy	+626,900	New	+$45.3M	0.39%	51
2014 Q1	–	Sell	-91,600	Closed	-$5.44M	–	2022
2013 Q4	$5.44M	Hold	91,600	–	–	0.03%	296
2013 Q3	$4.76M	Buy	91,600 +72,700	+385%	+$3.65M	0.05%	342
2013 Q2	$894K	Buy	+18,900	New	+$962K	0.01%	825

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Jefferies Group's AZN Position: Q3 2022 in Review

Jefferies Group reduced its AstraZeneca (AZN) stake by 18% in Q3 2022, selling an estimated $539K and leaving 19,171 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #587.

Jefferies Group first reported a position in AZN in Q2 2013 and has held it in 33 quarters since. The position peaked at $18.7M in Q2 2014. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Jefferies Group held 19,171 shares of AstraZeneca worth $2.1M as of Q3 2022.
Jefferies Group sold 4,252 AstraZeneca shares in Q3 2022, an estimated $539K.
AstraZeneca made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #587 holding.
Jefferies Group first reported a position in AstraZeneca in Q2 2013 and has held it in 33 quarters since.
Jefferies Group's AstraZeneca position peaked at $18.7M in Q2 2014.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.